HUP1700522A1 - Tricyclic compounds - Google Patents
Tricyclic compoundsInfo
- Publication number
- HUP1700522A1 HUP1700522A1 HU1700522A HUP1700522A HUP1700522A1 HU P1700522 A1 HUP1700522 A1 HU P1700522A1 HU 1700522 A HU1700522 A HU 1700522A HU P1700522 A HUP1700522 A HU P1700522A HU P1700522 A1 HUP1700522 A1 HU P1700522A1
- Authority
- HU
- Hungary
- Prior art keywords
- tricyclic compounds
- tricyclic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1700522A HUP1700522A1 (en) | 2017-12-15 | 2017-12-15 | Tricyclic compounds |
| TW107144825A TW201938171A (en) | 2017-12-15 | 2018-12-12 | Tricyclic compounds as vasopressin V1a receptor antagonists |
| ARP180103644A AR113934A1 (en) | 2017-12-15 | 2018-12-13 | TRICYCLIC COMPOUNDS AS ANTAGONISTS OF VASOPRESSIN RECEPTOR V1A |
| PCT/IB2018/060078 WO2019116325A1 (en) | 2017-12-15 | 2018-12-14 | Tricyclic compounds as vasopressin v1a receptor antagonists |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1700522A HUP1700522A1 (en) | 2017-12-15 | 2017-12-15 | Tricyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP1700522A1 true HUP1700522A1 (en) | 2019-06-28 |
Family
ID=89992590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1700522A HUP1700522A1 (en) | 2017-12-15 | 2017-12-15 | Tricyclic compounds |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR113934A1 (en) |
| HU (1) | HUP1700522A1 (en) |
-
2017
- 2017-12-15 HU HU1700522A patent/HUP1700522A1/en unknown
-
2018
- 2018-12-13 AR ARP180103644A patent/AR113934A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR113934A1 (en) | 2020-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201708456D0 (en) | Senolytic compounds | |
| GB201704327D0 (en) | Compounds | |
| GB201700814D0 (en) | Compounds | |
| GB201715342D0 (en) | Compounds | |
| GB201704325D0 (en) | Compounds | |
| GB201713962D0 (en) | Compounds | |
| GB201716871D0 (en) | Compounds | |
| ZA202100237B (en) | Tricyclic compounds | |
| GB201717051D0 (en) | Compounds | |
| GB201707938D0 (en) | Compounds | |
| GB201706162D0 (en) | Compounds | |
| IL249907A0 (en) | Tricyclic triazolic compounds | |
| GB201715786D0 (en) | Compounds | |
| GB201707856D0 (en) | Compounds | |
| GB201702221D0 (en) | Compounds | |
| GB201716369D0 (en) | Compounds | |
| GB201707852D0 (en) | Compounds | |
| GB201703282D0 (en) | Compounds | |
| HUP1700522A1 (en) | Tricyclic compounds | |
| HUP1800332A1 (en) | Tricyclic compounds ii | |
| GB201717050D0 (en) | Compounds | |
| GB201716688D0 (en) | Compounds | |
| GB201716374D0 (en) | Compounds | |
| GB201716352D0 (en) | Compounds | |
| GB201716392D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |